Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic

March 30, 2017 updated by: Vanderbilt University Medical Center

Childhood Cancer Survivors' Knowledge of Their Diagnosis, Treatment, and Risk of Late Effects: The Impact of Care in a Specialized Survivorship Clinic

This two-part research study will compare childhood cancer survivors receiving specialized follow-up care in the REACH for Survivorship clinic to patients receiving routine follow-up care.

Study Overview

Study Type

Observational

Enrollment (Actual)

188

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Vanderbilt-Ingram Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 21 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Fifty new cancer patients in the REACH for Survivorship clinic, fifty returning cancer patients in the REACH for Survivorship clinic, and one hundred routine care cancer patients are expected to enroll in this study.

Description

Inclusion Criteria:

  • Treatment for primary malignancy per risk-adapted protocol
  • Age ≤ 21 years at time of diagnosis
  • Currently alive without evidence of disease
  • Off therapy for no more than 15 years

Exclusion Criteria:

-Patients who have received a bone marrow transplant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Routine Patient Care
  • Standard Interview (2-15 years from last treatment)
  • Demographic data interview (pre-initial study interview)
Previously-enrolled REACH Clinic Patients
  • REACH Clinic Visit(initial or regular)
  • Post-REACH Clinic Interview (3mos from initial or regular clinic visit)
  • Demographic data interview(pre-initial study interview)
New REACH Clinic Patients
  • Pre-REACH Clinic Interview(2-15 yrs from last treatment)
  • REACH Clinic Visit(initial or regular)
  • Post-REACH Clinic Interview(1mo from initial clinic visit)
  • Post-REACH Clinic Interview(3mos from initial or regular clinic visit)
  • Demographic data interview(pre-initial study interview)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge gained by attending a multispecialty Survivorship Clinic which will be measured by comparison of self report with medical record data in both cross-sectional and longitudinal approach.
Time Frame: 12 months
In addition to data from patient interviews, a review of medical records will include general patient demographic data as well as data regarding cancer diagnosis, treatment and ongoing follow-up care.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Characterizing how the initial consultation in a specialized clinic impacts childhood cancer survivors' knowledge of their cancer diagnosis, treatment, and risk of late effects by comparing patient's understanding among 3 sampled timepoints.
Time Frame: pre-clinic and a post-clinic interviews at 1 and 3 months.
pre-clinic and a post-clinic interviews at 1 and 3 months.
An analysis of differences in relative levels of recommended screening for late effects that childhood cancer survivors have received based on the type of their long-term follow-up care comparing medical records against Survivorship Care Plan.
Time Frame: 12 months
Scored responses will allow for quantitative analysis of differences within and between the cohorts of patients
12 months
A qualitative evaluation of program feedback will serve to improve the care provided in the REACH for Survivorship clinic
Time Frame: 12 months
This data will be evaluated qualitatively for trends.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2010

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

October 15, 2010

First Submitted That Met QC Criteria

October 18, 2010

First Posted (Estimate)

October 19, 2010

Study Record Updates

Last Update Posted (Actual)

April 4, 2017

Last Update Submitted That Met QC Criteria

March 30, 2017

Last Verified

March 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • VICCREACH1038

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Childhood Cancer

Clinical Trials on interview

3
Subscribe